Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/126476
Full metadata record
DC FieldValueLanguage
dc.creatorPalma, P-
dc.creatorCosta, A-
dc.creatorDuro, R-
dc.creatorNeves, N-
dc.creatorAbreu, C-
dc.creatorSarmento, A-
dc.date.accessioned2020-03-02T10:34:01Z-
dc.date.available2020-03-02T10:34:01Z-
dc.date.issued2018-
dc.identifier.issn1471-2334-
dc.identifier.urihttps://hdl.handle.net/10216/126476-
dc.description.abstractBACKGROUND: Cytomegalovirus (CMV) reactivation with neurological involvement in patients with acquired immunodeficiency syndrome (AIDS) is increasingly rare since the introduction of antiretroviral therapy (ART). Manifestations include encephalitis, myelitis, polyradiculopathy and, less commonly, mononeuritis multiplex (MNM). We report a case of disseminated CMV disease with gastrointestinal and peripheral and central nervous system involvement in a patient with AIDS, manifesting primarily as MNM. CASE PRESENTATION: A 31-year old woman with AIDS presented with a clinical picture of MNM. Electromyography confirmed the clinical findings. CMV DNA was detected in cerebrospinal fluid (CSF) and blood. Gastrointestinal involvement was histologically documented. HIV RNA was also detected in CSF and brain MRI was consistent with HIV encephalopathy. A diagnosis of disseminated CMV disease (with esophagitis, colitis, encephalitis and MNM) and HIV encephalopathy was made. Treatment consisted of ganciclovir and foscarnet, followed by maintenance therapy with valganciclovir. Evolution was favorable and valganciclovir was stopped after sustained immune recovery following ART initiation. CONCLUSION: We discuss the diagnostic approach to CMV neurological disease, with a focus on MNM and CMV encephalitis. Combination therapy with ganciclovir and foscarnet should be considered for all forms of neurological involvement, although available data are scarce. Since there is significant overlap between CMV encephalitis and HIV encephalopathy, ART drugs with higher CSF penetration may have to be considered. ART and immune recovery are essential to improve outcomes.-
dc.language.isoeng-
dc.publisherBMC-
dc.relation.ispartofBMC Infectious Diseases, vol.18(1):554-
dc.rightsopenAccess-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.rights.urihttps://creativecommons.org/publicdomain/zero/1.0/-
dc.subject.meshAcquired Immunodeficiency Syndrome-
dc.subject.meshAdult-
dc.subject.meshAIDS Dementia Complex-
dc.subject.meshAIDS-Related Opportunistic Infections-
dc.subject.meshCytomegalovirus-
dc.subject.meshCytomegalovirus Infections-
dc.subject.meshFemale-
dc.subject.meshHIV-
dc.subject.meshHIV Infections-
dc.subject.meshHumans-
dc.subject.meshMononeuropathies-
dc.subject.meshVirus Activation-
dc.titleMononeuritis multiplex: an uncommon neurological manifestation of cytomegalovirus reactivation in an HIV-infected patient-
dc.typeArtigo em Revista Científica Internacional-
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde-
dc.identifier.doi10.1186/s12879-018-3501-2-
dc.relation.publisherversionhttps://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3501-2-
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.1186-s12879-018-3501-2.pdf1.52 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons